BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 26, 2006
View Archived Issues
Glenmark presents new CB2 agonists as promising antihyperalgesic candidates
Read More
Silenor effective at inducing and maintaining sleep in transient insomnia patients
Read More
Phase I results warrant abagovomab's further evaluation
Read More
GPCR inhibitor blocks cancer growth, induces apoptosis and synergizes with anticancer drugs
Read More
Sazetidine-A: a new desensitizing nicotinic ligand
Read More
Recent patents report new treatment strategies for respiratory disorders
Read More
Therapeutic agents for arteriosclerosis, hypertension, etc. disclosed in recent patents
Read More
Recent patent literature discloses novel analgesic agents
Read More
Orexo receives license payment from Endo for Rapinyl
Read More
Acadia to support new substance abuse startup company Abbey
Read More
Enrollment over half complete in phase IIb trial of CF-101 in rheumatoid arthritis
Read More
Phase II study of HCV-796 begins dosing
Read More
Preliminary three-month findings from endometriosis study of Proellex
Read More
MVA-BN polytope vaccine begins new trials in Europe
Read More
New trial studies HuMax-EGFr with chemoradiation for head and neck cancer
Read More
Dharma's iontophoretic drug delivery system shows promise in phase I study
Read More
EvoGenix completes first project under GSK collaboration
Read More
ASF-1057 begins phase IIb studies for seborrheic dermatitis
Read More
Alantos and Servier collaborate on DPP-IV inhibitor ALS-2-0426
Read More
Amgen completes acquisition of Avidia
Read More
Termination of Takeda and BioNumerik's Tavocept agreement
Read More
Renovo: pipeline update
Read More
Aridol approved in Sweden
Read More
FDA approves Tyzeka for chronic hepatitis B
Read More
Promising preliminary results for ASF-1096 formulation in cutaneous lupus erythematosus
Read More
New clinical study of levetiracetam for Tourette syndrome
Read More
Memory Pharmaceuticals discloses MEM-3454 preclinical data at the SfN meeting
Read More
The glycine transporter-1 inhibitor SSR-103800 shows promise in animal models of schizophrenia
Read More
Targeting Fc receptors: a promising approach for the treatment of B-cell malignancies
Read More
Mahonia aquifolium alkaloids may be useful against Malassezia skin infections
Read More